FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: PeakClear all
PLUVICTO
lutetium lu 177 vipivotide tetraxetan
Peak
Novartis
INTRAVENOUS · SOLUTION
2022
NDA
0/100
POKONZA
potassium chloride
Peak
ORAL · SOLUTION
2014
NDA
0/100
POMALYST
pomalidomide
Peak
Bristol Myers Squibb
ORAL · CAPSULE
2013
NDA
0/100
PONVORY
ponesimod
Peak
Vanda Pharmaceuticals
ORAL · TABLET
2021
NDA
0/100
POSIMIR
bupivacaine
Peak
INFILTRATION · SOLUTION
2021
NDA
0/100
POTASSIUM CHLORIDE
potassium chloride
Peak
ORAL · SOLUTION
2014
NDA
0/100
POTASSIUM PHOSPHATES
potassium phosphate, dibasic; potassium phosphate, monobasic
Peak
INTRAVENOUS · SOLUTION
2019
NDA
0/100
POTASSIUM PHOSPHATES
potassium phosphates
Peak
Fresenius Kabi
INTRAVENOUS · SOLUTION
2019
NDA
0/100
POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
potassium phosphates
Peak
Fresenius Kabi
INTRAVENOUS · SOLUTION
2019
NDA
0/100
PRADAXA
dabigatran etexilate mesylate
Peak
Boehringer Ingelheim
ORAL · CAPSULE
deep venous thrombosispulmonary embolism in adult patients+6
2010
NDA
0/100
PRECEDEX
dexmedetomidine hydrochloride
Peak
Pfizer
INJECTION · INJECTABLE
1999
NDA
0/100
PREVDUO
neostigmine methylsulfate and glycopyrrolate
Peak
R-Pharm US
INTRAVENOUS · SOLUTION
2023
NDA
0/100
PREVYMIS
letermovir
Peak
Merck & Co.
INTRAVENOUS · SOLUTION
2017
SMNDA
0/100
PREZCOBIX
cobicistat; darunavir ethanolate
Peak
Johnson & Johnson
ORAL · TABLET
2015
NDA
0/100
PROCYSBI
cysteamine bitartrate
Peak
Amgen
ORAL · GRANULE, DELAYED RELEASE
2020
NDA
0/100
PROCYSBI
cysteamine bitartrate
Peak
Amgen
ORAL · CAPSULE, DELAYED RELEASE
2013
NDA
0/100
PROLENSA
bromfenac sodium
Peak
Bausch + Lomb
OPHTHALMIC · SOLUTION/DROPS
2013
NDA
0/100
PURIFIED CORTROPHIN GEL
repository corticotropin
Peak
ANI Pharmaceuticals
INJECTION · INJECTABLE
1954
NDA
0/100
PYLARIFY
piflufolastat f-18
Peak
Progenicyte Therapeutics
INTRAVENOUS · SOLUTION
2021
NDA
0/100
PYRUKYND
mitapivat
Peak
Agios Pharmaceuticals
ORAL · TABLET
2022
NDA
0/100
QBRELIS
lisinopril
Peak
R-Pharm US
ORAL · SOLUTION
2016
SMNDA
0/100
QBREXZA
glycopyrronium
Peak
Journey Medical
TOPICAL · CLOTH
2018
NDA
0/100
QDOLO
tramadol hydrochloride
Peak
Athena Bioscience
ORAL · SOLUTION
2020
NDA
0/100
QELBREE
viloxazine hydrochloride
Peak
Supernus Pharmaceuticals
ORAL · CAPSULE, EXTENDED RELEASE
2021
NDA
0/100